Hypertension as a manifestation of COVID‐19 pneumonia

Bekbossynova, Makhabbat; Tauekelova, Ainur

doi:10.1002/ccr3.4720

Cited by 1 publication

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…( 7 , 8 ) Considering the high infectivity rate of the virus and the number of people testing positive on both rapid antigen (RATs) and PCR tests daily, the question of the need for a post-COVID follow-up arises. The papers found during the authors’ literature search on the topic of post-COVID hypertension estimated the incidence of arterial hypertension following COVID-19 to be between 9 and 12% ( 5 , 9 ). Our results suggest that, in a sample of 200 patients, the incidence is about 16%, and it is a relatively common occurrence.…”

Section: Discussionmentioning

confidence: 99%

“…This pattern of overseeing one of the deadliest silent killers of today is unfortunately also noticeable in post-COVID research. While it has been established that COVID-19 can both cause “de novo” onset hypertension and worsen existing ones by interacting with both the RAAS ( 1 ) and endothelin ( 2 ) systems, a review of the literature describing the clinical aspects of the phenomenon produced sparse results, with the authors finding only a single survey ( 3 ), a retrospective review ( 4 ), and a case study ( 5 ) regarding hypertension related to COVID-19. The aim of this paper, therefore, is to provide a window into this under-researched topic by describing a patient population suffering from post-COVID hypertension seen and treated by the authors, describing both their general attributes (age or gender) and specific clinical entities (arterial blood pressure, laboratory values, antihypertensive therapy, and other clinical conditions with which they are affected).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Arterial hypertension following COVID-19: A retrospective study of patients in a Central European tertiary care center

Delalić

2022

ACC

View full text Add to dashboard Cite

The aim of this study was to determine the frequency of newly verified or worsened existing hypertension in patients who had coronavirus 2019 .to be categorized as a COViD-19 patient, a positive reverse-transcription polymerase chain reaction test at a single point in time was required. The patients' age, history, laboratory values and antihypertensive therapy of patients were recorded.in one year, 32 of 199 patients studied had either newly verified (15) or worsened existing (17) arterial hypertension. Among those patients, the median time from a verified infection to the onset of symptoms was 3 months. when the patients were divided into groups, 4 were in the acute, 11 in the sub-acute, 8 in the chronic and 9 in the "long COViD" group. Compared to the rest of the study population, patients presenting with arterial hypertension had significantly higher systolic (median 141 mmhg vs 130 mmhg, p<0.001) and diastolic (median 93 mmhg vs 80 mmhg, p<0.001) blood pressure and were significantly younger (median 51 vs 59 years, p 0.032).Arterial hypertension following COViD-19, either newly verified or worsened existing, is a relatively common occurrence (16% of our patient pool), indicating that more effort should be directed at evaluating the blood pressure values of patients following COViD-19.

show abstract

Section: Discussionmentioning

confidence: 99%